Lucus Advisors LLC lowered its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 39.3% during the second quarter, Holdings Channel reports. The firm owned 2,440 shares of the healthcare conglomerate’s stock after selling 1,578 shares during the period. Lucus Advisors LLC’s holdings in UnitedHealth Group were worth $345,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of UNH. RKL Wealth Management LLC purchased a new position in UnitedHealth Group during the first quarter worth about $592,000. Glenmede Trust Co. NA raised its position in UnitedHealth Group by 14.2% in the first quarter. Glenmede Trust Co. NA now owns 184,566 shares of the healthcare conglomerate’s stock worth $23,789,000 after buying an additional 23,003 shares during the last quarter. Investment Centers of America Inc. raised its position in UnitedHealth Group by 105.8% in the first quarter. Investment Centers of America Inc. now owns 5,181 shares of the healthcare conglomerate’s stock worth $670,000 after buying an additional 2,663 shares during the last quarter. Sii Investments Inc. WI raised its position in UnitedHealth Group by 9.8% in the first quarter. Sii Investments Inc. WI now owns 17,535 shares of the healthcare conglomerate’s stock worth $2,260,000 after buying an additional 1,567 shares during the last quarter. Finally, Sanders Morris Harris Inc. purchased a new position in UnitedHealth Group during the first quarter worth about $447,000. 85.78% of the stock is currently owned by institutional investors.
UnitedHealth Group Inc. (NYSE:UNH) traded down 1.08% during mid-day trading on Monday, hitting $138.49. The stock had a trading volume of 2,724,399 shares. The firm has a market capitalization of $131.90 billion, a price-to-earnings ratio of 21.67 and a beta of 0.57. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The stock’s 50 day moving average price is $138.30 and its 200 day moving average price is $136.18.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.07. The company earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. Analysts forecast that UnitedHealth Group Inc. will post $7.90 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.81%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
UNH has been the topic of a number of research analyst reports. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $178.00 target price on shares of UnitedHealth Group in a report on Tuesday, September 6th. Royal Bank Of Canada lifted their target price on UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a report on Wednesday, July 20th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 29th. Finally, Zacks Investment Research lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Monday, July 18th. One analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.